Open AccessInitial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study
Author(s) -
Debdulal Chakraborty,
Aniruddha Maiti,
Sabyasachi Sengupta,
Soumen Mondal,
Krishnendu Nandi,
Somnath Chakraborty
Publication year - 2022
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_2513_21
Subject(s) - medicine , pro re nata , ophthalmology , retrospective cohort study , confidence interval , surgery , ranibizumab , bevacizumab , chemotherapy
To report the initial experience of managing treatment-resistant and treatment-naïve eyes with polypoidal choroidal vasculopathy (PCV) by using brolucizumab 6 mg.